Cardinal Health, Inc. (NYSE:CAH) Given Average Rating of “Hold” by Analysts

Cardinal Health, Inc. (NYSE:CAHGet Rating) has been given a consensus recommendation of “Hold” by the twelve ratings firms that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $59.90.

A number of brokerages have issued reports on CAH. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and raised their target price for the stock from $55.00 to $68.00 in a report on Wednesday, May 18th. StockNews.com lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, May 6th. Zacks Investment Research raised Cardinal Health from a “sell” rating to a “hold” rating and set a $55.00 target price on the stock in a research report on Monday, March 14th. Credit Suisse Group dropped their target price on Cardinal Health from $60.00 to $58.00 and set a “neutral” rating on the stock in a research report on Friday, February 4th. Finally, Robert W. Baird lifted their target price on Cardinal Health from $52.00 to $57.00 in a research report on Friday, February 4th.

Cardinal Health stock opened at $55.80 on Monday. The business’s 50-day simple moving average is $58.55 and its 200 day simple moving average is $53.74. The stock has a market cap of $15.20 billion, a price-to-earnings ratio of 8.51, a P/E/G ratio of 6.64 and a beta of 0.82. Cardinal Health has a 12-month low of $45.85 and a 12-month high of $64.53. The company has a quick ratio of 0.54, a current ratio of 1.08 and a debt-to-equity ratio of 5.33.

Cardinal Health (NYSE:CAHGet Rating) last issued its earnings results on Thursday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.54 by ($0.09). Cardinal Health had a positive return on equity of 155.24% and a negative net margin of 0.54%. The company had revenue of $44.84 billion for the quarter, compared to the consensus estimate of $43.20 billion. During the same quarter last year, the business posted $1.53 EPS. Cardinal Health’s quarterly revenue was up 14.2% on a year-over-year basis. As a group, sell-side analysts expect that Cardinal Health will post 5.19 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, July 15th. Shareholders of record on Friday, July 1st will be paid a $0.4957 dividend. This represents a $1.98 dividend on an annualized basis and a yield of 3.55%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.49. The ex-dividend date of this dividend is Thursday, June 30th. Cardinal Health’s dividend payout ratio (DPR) is currently 29.88%.

A number of hedge funds have recently bought and sold shares of the business. Manchester Capital Management LLC lifted its stake in shares of Cardinal Health by 60.4% during the 1st quarter. Manchester Capital Management LLC now owns 494 shares of the company’s stock worth $28,000 after buying an additional 186 shares during the last quarter. AdvisorNet Financial Inc lifted its stake in shares of Cardinal Health by 23.3% during the 1st quarter. AdvisorNet Financial Inc now owns 1,028 shares of the company’s stock worth $58,000 after buying an additional 194 shares during the last quarter. KB Financial Partners LLC lifted its stake in shares of Cardinal Health by 2.5% during the 1st quarter. KB Financial Partners LLC now owns 8,267 shares of the company’s stock worth $469,000 after buying an additional 199 shares during the last quarter. Benjamin F. Edwards & Company Inc. lifted its stake in shares of Cardinal Health by 23.8% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 1,041 shares of the company’s stock worth $59,000 after buying an additional 200 shares during the last quarter. Finally, Signaturefd LLC lifted its stake in shares of Cardinal Health by 26.8% during the 1st quarter. Signaturefd LLC now owns 955 shares of the company’s stock worth $54,000 after buying an additional 202 shares during the last quarter. Hedge funds and other institutional investors own 84.26% of the company’s stock.

Cardinal Health Company Profile (Get Rating)

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

See Also

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.